Menu
+
+
+
+
+
+
The partners added non-human indications to a 2005 deal that granted Spectrum exclusive, worldwide rights to develop and commercialize Altair's RenaZorb family of compounds...
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
